Francine E Garrett-Bakelman

Francine E Garrett-Bakelman

UNVERIFIED PROFILE

Are you Francine E Garrett-Bakelman?   Register this Author

Register author
Francine E Garrett-Bakelman

Francine E Garrett-Bakelman

Publications by authors named "Francine E Garrett-Bakelman"

Are you Francine E Garrett-Bakelman?   Register this Author

17Publications

739Reads

41Profile Views

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.

Science 2019 04;364(6436)

Northwestern University, Evanston, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aau8650DOI Listing
April 2019

Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.

Cancer Cell 2018 01 21;33(1):44-59.e8. Epub 2017 Dec 21.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108173051
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2017.11.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760367PMC
January 2018

The N-methyladenosine (mA)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.

Nat Med 2017 Nov 18;23(11):1369-1376. Epub 2017 Sep 18.

Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677536PMC
November 2017

Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation.

Epigenomics 2016 07 19;8(7):945-57. Epub 2016 Jul 19.

Division of Hematology/Medical Oncology, Department of Medicine, Weill Cornell Medicine, 413 East 69th Street, BRB 14th floor, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi-2016-0008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066133PMC
July 2016

An optimized algorithm for detecting and annotating regional differential methylation.

BMC Bioinformatics 2013 10;14 Suppl 5:S10. Epub 2013 Apr 10.

Department of Physiology and Biophysics,Weill Cornell Medical College, 1305 York Ave., New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-14-S5-S10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622633PMC
December 2013

Differentiation therapy for IDH1/2 mutant malignancies.

Cell Res 2013 Aug 4;23(8):975-7. Epub 2013 Jun 4.

Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cr.2013.73DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731561PMC
August 2013